Filing Flows › Johnson & Johnson (JNJ) › MEDTECH revenue
Johnson & Johnson (JNJ) MEDTECH revenue by quarter
Johnson & Johnson's MEDTECH revenue was $8.6B in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $8.0B (Q1 2025) to $8.9B (Q2 2026).
| Quarter | MEDTECH revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.6B | -3% | +3% |
| Q2 2026 | $8.9B | +3% | +5% |
| Q1 2026 | $8.6B | -2% | +8% |
| Q4 2025 | $8.8B | +4% | — |
| Q3 2025 | $8.4B | -1% | — |
| Q2 2025 | $8.5B | +6% | — |
| Q1 2025 | $8.0B | — | — |
Q3 2026 at a glance
Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Johnson & Johnson's MEDTECH revenue?
Johnson & Johnson's MEDTECH revenue was $8.6B in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Johnson & Johnson's MEDTECH revenue changed?
Over the last 7 quarters it ranged from $8.0B (Q1 2025) to $8.9B (Q2 2026).